Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10032751HBVENSG00000011677.13protein_codingGABRA3NoNo2556P34903
TVIS20002957HPVENSG00000011677.13protein_codingGABRA3NoNo2556P34903
TVIS20031069HPVENSG00000011677.13protein_codingGABRA3NoNo2556P34903
TVIS20030899HPVENSG00000011677.13protein_codingGABRA3NoNo2556P34903
TVIS44021579HTLV-1ENSG00000011677.13protein_codingGABRA3NoNo2556P34903
TVIS44024241HTLV-1ENSG00000011677.13protein_codingGABRA3NoNo2556P34903
TVIS44014377HTLV-1ENSG00000011677.13protein_codingGABRA3NoNo2556P34903
TVIS44029002HTLV-1ENSG00000011677.13protein_codingGABRA3NoNo2556P34903
TCGA Plot Options
Drug Information
GeneGABRA3
DrugBank IDDB00371
Drug NameMeprobamate
Target IDBE0000523
UniProt IDP34903
Regulation Typeagonist
PubMed IDs9067327; 19244096
CitationsRho JM, Donevan SD, Rogawski MA: Barbiturate-like actions of the propanediol dicarbamates felbamate and meprobamate. J Pharmacol Exp Ther. 1997 Mar;280(3):1383-91.@@Gonzalez LA, Gatch MB, Taylor CM, Bell-Horner CL, Forster MJ, Dillon GH: Carisoprodol-mediated modulation of GABAA receptors: in vitro and in vivo studies. J Pharmacol Exp Ther. 2009 May;329(2):827-37. doi: 10.1124/jpet.109.151142. Epub 2009 Feb 24.
GroupsApproved; Illicit
Direct ClassificationCarbamate esters
SMILESCCCC(C)(COC(N)=O)COC(N)=O
PathwaysCapecitabine Metabolism Pathway; Capecitabine Action Pathway
PharmGKBPA450377
ChEMBLCHEMBL979